The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126940291 12694029 1 I 2015 20160601 20160829 20160829 PER US-JNJFOC-20160601758 JANSSEN 0.00 E F Y 54.43000 KG 20160829 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126940291 12694029 1 SS CONCERTA METHYLPHENIDATE HYDROCHLORIDE 1 Oral Y U 16BG195X 0 72 MG SUSTAINED RELEASE TABLETS
126940291 12694029 2 PS CONCERTA METHYLPHENIDATE HYDROCHLORIDE 1 Oral DAILY WHEN THE PATIENT GOT UP Y U 16BG195X 21121 72 MG SUSTAINED RELEASE TABLETS
126940291 12694029 3 I CYANOCOBALAMIN. CYANOCOBALAMIN 1 Unknown Y 0 UNSPECIFIED
126940291 12694029 4 I CYANOCOBALAMIN. CYANOCOBALAMIN 1 Unknown Y 0 UNSPECIFIED
126940291 12694029 5 C CLONAZEPAM. CLONAZEPAM 1 Unknown 0 .5 MG UNSPECIFIED
126940291 12694029 6 C LISINOPRIL. LISINOPRIL 1 Unknown 0 10 MG UNSPECIFIED QD
126940291 12694029 7 C PLAVIX CLOPIDOGREL BISULFATE 1 Unknown 0 75 MG UNSPECIFIED QD
126940291 12694029 8 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 Unknown 0 150 MG UNSPECIFIED QD
126940291 12694029 9 C PREVACID LANSOPRAZOLE 1 Unknown 0 30 MG UNSPECIFIED QD
126940291 12694029 10 C ATENOLOL. ATENOLOL 1 Unknown 0 50 MG UNSPECIFIED QD
126940291 12694029 11 C ISOSORBIDE MONONITRATE. ISOSORBIDE MONONITRATE 1 Unknown 0 60 MG UNSPECIFIED QD
126940291 12694029 12 C ASPIRIN. ASPIRIN 1 Unknown 0 81 MG UNSPECIFIED QD
126940291 12694029 13 C FUROSEMIDE. FUROSEMIDE 1 Unknown 0 20 MG UNSPECIFIED QD
126940291 12694029 14 C NITROSTAT NITROGLYCERIN 1 Unknown 0 .4 MG UNSPECIFIED
126940291 12694029 15 C VITAMIN D CHOLECALCIFEROL 1 Unknown 1000 (UNITS UNPECIFIED) 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126940291 12694029 1 Attention deficit/hyperactivity disorder
126940291 12694029 2 Attention deficit/hyperactivity disorder
126940291 12694029 3 Nutritional supplementation
126940291 12694029 4 Nutritional supplementation
126940291 12694029 5 Anxiety
126940291 12694029 6 Blood pressure abnormal
126940291 12694029 7 Cardiac disorder
126940291 12694029 8 Neuropathy peripheral
126940291 12694029 9 Dyspepsia
126940291 12694029 10 Blood pressure abnormal
126940291 12694029 11 Cardiac disorder
126940291 12694029 12 Cardiac disorder
126940291 12694029 13 Diuretic therapy
126940291 12694029 14 Cardiac disorder
126940291 12694029 15 Nutritional supplementation

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126940291 12694029 Body height decreased
126940291 12694029 Drug dose omission
126940291 12694029 Drug ineffective
126940291 12694029 Drug interaction
126940291 12694029 Feeling abnormal
126940291 12694029 Product use issue
126940291 12694029 Vitamin B12 decreased
126940291 12694029 Vitamin B12 increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126940291 12694029 1 201602 0
126940291 12694029 2 2007 201602 0
126940291 12694029 4 201603 0